A股異動丨重慶啤酒(600132.SH)漲停創新高 與嘉士伯合資設立重慶嘉釀
格隆匯9月14日丨重慶啤酒(600132.SH)高開漲停,報98.23元創新高,暫成交1.21億元,最新總市值475.4億元。重慶啤酒11日晚公告,公司向嘉士伯香港購買無任何權利負擔的重慶嘉釀48.58%股權,對價6.43億元;重慶啤酒以重啤擬注入業務(對價43.65億元)認購一定比例的重慶嘉釀新增註冊資本,嘉士伯諮詢以A包資產(對價為53.76億元)認購一定比例的重慶嘉釀新增註冊資本;該增資完成後,重慶啤酒持有重慶嘉釀51.42%股權。民生證券認為,交易完成後公司生產效率將得到持續提升,未來業績增速將有望快於可比公司平均水平,維持“推薦”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.